TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A study published in Advanced Science found that STING signaling in bone marrow macrophages was linked to age-related bone loss in mice. Removing STING from bone marrow cells protected older mice from bone loss, although young mice lacking it had lower bone density. The findings point to a possible research target, not a proven way to prevent osteoporosis in people.
A study published in Advanced Science has linked activation of the STING pathway in bone marrow immune cells to age-related bone loss in mice, identifying a possible target for future osteoporosis research. Mice lacking STING in bone marrow cells had lower bone density when young but were protected against bone loss later in life, so the findings do not establish that blocking the pathway would prevent osteoporosis in people.
The researchers examined bone marrow macrophages, immune cells that help defend against pathogens and can also promote inflammation. They found that STING activity in these cells increased with age. To test its role, the team studied mice lacking the STING protein in bone marrow cells. The effects differed by age: young mice had reduced bone density, while older mice were protected against bone loss.
The study also traced a possible signal between bone marrow adipocytes—fat cells in the marrow—and macrophages. In laboratory experiments, adipocytes isolated from older mice promoted STING activation when cultured with macrophages from young mice. The researchers identified DPP4, a protein secreted by the aging fat cells, as a factor that activated STING and was associated with inflammation and bone loss.
Downstream of STING activation, the team reported a reduction in NAD+ in nearby bone marrow cells. NAD+ supports processes including metabolism and DNA repair. The researchers found that reducing NAD+ in bone marrow stem cells impaired their ability to develop into cells that form and repair bone. The results connect changes across three cell types, but the supplied report describes mouse and cell experiments, not a clinical trial.
A Potential Target, Not a Treatment
Osteoporosis involves weakened bones and can increase the risk of fractures, particularly with age. The study offers a possible explanation for how inflammation in aging bone marrow may interfere with the cells needed to maintain and repair bone. By linking aging marrow fat cells, macrophage STING signaling and NAD+ depletion, the researchers identify a chain of biological events that could guide further investigation.
The age-dependent results also caution against treating STING as a simple target to switch off. Its absence was associated with lower bone density in young mice but protection in older animals. If the pathway is explored as a therapeutic target, age and the effects on other immune and bone functions will need careful study. The work does not show that a STING-blocking drug can prevent fractures or osteoporosis in humans.
As an affiliate, we earn on qualifying purchases.
How Aging Marrow May Affect Bone
Bone marrow contains more than the cells involved in blood and immune function. It also includes fat cells, stem cells and other components that help regulate bone formation and repair. With aging, marrow fat and inflammation-promoting immune activity can increase, creating changes in the environment in which bone-forming cells develop.
STING is part of the innate immune system, which responds to infection and cellular stress. The study, by Li and colleagues, examined whether this pathway contributes to skeletal aging. The report says the research was published by Wiley in Advanced Science; its title is “Bone Marrow Macrophage STING Signaling is a Direct Nexus Linking Marrow Adipose Expansion to NAD+ Depletion and Osteogenic Decline in Skeletal Aging.”
“STING signaling in bone marrow macrophages [is] a pivotal integration hub.”
— The study authors, as quoted in the News-Medical report
Human Effects Remain Unknown
The supplied report does not describe studies in people, clinical testing, or a treatment that targets STING to prevent osteoporosis. It is therefore unclear whether the same sequence of events occurs in human bone marrow or whether changing STING activity would preserve bone density in patients.
The findings also leave open how researchers might target the pathway without affecting its normal immune functions or bone development. The reported age difference in mice underscores that uncertainty. The source does not provide enough detail to assess the size of the effects, the full experimental design, or whether other factors could account for some of the results.
Further Testing Is Needed
The next steps would be to test whether the reported links hold across additional models and to clarify how DPP4 and NAD+ contribute to STING-related changes in bone. Research would also need to establish whether a safe way to alter this pathway can protect bone without harmful effects, including at different ages.
Until human studies evaluate those questions, the findings should be treated as an early biological lead rather than a prevention strategy. People concerned about osteoporosis should seek advice from a qualified health professional; this study does not change established clinical care.
Key Questions
What did the study find?
Researchers found that STING activity in bone marrow macrophages increased with age in their study. In mice, removing STING from bone marrow cells was linked to protection from bone loss later in life, but lower bone density when young.
How might marrow fat cells be involved?
In laboratory experiments, fat cells from older mice promoted STING activation in macrophages. The researchers identified the secreted protein DPP4 as one factor involved in that response.
Does this mean STING-targeting treatment can prevent osteoporosis?
No. The report describes research in mice and cell experiments, not a tested osteoporosis treatment or evidence of prevention in people.
Why did the effects differ between young and older mice?
The study reported lower bone density in young mice lacking STING and protection against bone loss in older mice. The supplied report does not fully explain the age-dependent difference.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
